Cost-effectiveness analysis of simeprevir with daclatasvir for non-cirrhotic genotype-1b-naïve patients plus chronic hepatitis C

  1. Gimeno-Ballester, V.
  2. Mar, J.
  3. San Miguel, R.
Aldizkaria:
Expert Review of Pharmacoeconomics and Outcomes Research

ISSN: 1744-8379,  1473-7167

Argitalpen urtea: 2016

Alea: 16

Zenbakia: 2

Orrialdeak: 285-294

Mota: Artikulua

DOI: 10.1586/14737167.2015.1081061 GOOGLE SCHOLAR
Datuen iturria: Scopus